Home / Health care / St. Jude proton therapy hits milestone in childhood cancer fight stat : USA TODAY
alibaba.com, cpa campaign, lead generation, lead campaign, smart match lander, intelligent lander, a

St. Jude proton therapy hits milestone in childhood cancer fight stat : USA TODAY

referring to (Photo: Yalonda M. James, The Commercial Appeal)Some of the older patients who have completed proton Therapy say there’s no discomfort.
January 18, 2017 – 15-year-old patient Megan Vess undergoes a treatment in the Proton Therapy Center at the St. Jude Children’s Research Hospital on Wednesday.
“Everything we do in the proton Therapy center is image-guided,” Saunders said.
She had been treated at St. Jude earlier for acute lymphoblastic leukemia.
Tinkle calls proton Therapy an “exciting” advance.

St. Jude proton therapy hits milestone in childhood cancer fight

as declared in Both babies went into complete remission within 28 days after receiving the therapy, and have since remained leukemia-free for 10 and 16 months.
Instead of fine-tuning the infants’ own T cells to fight their cancer, the researchers made a “universal” T cell that eradicated the leukemia from both subjects’ blood.
Such cell-based approaches have been difficult to implement in young children, a population in which B cell acute lymphoblastic leukemia (ALL) is highly prevalent, representing 25% of all pediatric cancer cases in the United States.
In search of a better alternative, Waseem Qasim and colleagues developed a novel approach that overcomes this significant obstacle to current T cell therapies.
Two infants diagnosed with a relapsed form of childhood cancer who had previously exhausted all other treatment options remain disease-free after receiving a first-in-human experimental therapy that uses genetically engineered T cells, a new analysis reports.
Universal CAR T cell therapy helps beat a hard-to-treat pediatric cancer -- ScienceDaily

as declared in Treating head and neck Cancer patients with a twice-daily radiation therapy combined with chemotherapy could save more lives, according to new research presented at the European Cancer Congress 2017.
Dr Petit told the Congress: “There are a number of new treatments that have shown promise in head and neck Cancer trials.
Around 600,000 people are diagnosed with head and neck Cancer worldwide each year.
They discovered that the twice-daily treatment, when combined with chemotherapy, cut deaths by 20% compared to the best standard treatment of once-daily radiotherapy with chemotherapy.
The twice-daily treatment is known as hyperfractionated radiotherapy.

about the details read more from here

This content may collect you by Victoria Hunter

To follow all the new news about Therapy

Check Also

picture.jpg

medicinal Marijuana For Kids by Cancer disease Broadly Supported By Doctors

As it stated in The 44% response average resulted in 288 responders who answered questions …